CTSO cytosorbents.com: Long-Term Debt to Capital Coefficient

Corporate emblem and logo of CytoSorbents Corp (CTSO)

The ratio of long-term debt to equity for Cytosorbents (CTSO) currently holds around 0.00. Cytosorbents generates revenue from the supply of disposable toxin-removal cartridges to intensive care units. Automated production of consumables ensures high margins. Despite the slow pace of approvals in the US, strong patents for sorption columns maintain business stability in Europe.

CTSO - cytosorbents.com Long-Term Debt to Equity over the range 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for CytoSorbents Corp (CTSO)

- price and consensus price forecast:
Price CytoSorbents Corp.|CTSO - Analyst Consensus Forecast
- market capitalization data:
Market Value CytoSorbents Corporation|CTSO - Enterprise Value
- book capitalization data:
Net Asset Value per Share Cytosorbents|CTSO - Company Book Value|Market Value to Book Value cytosorbents.com|CTSO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Cytosorbents|CTSO - Long-Term Debt to Equity|Current Liabilities to Equity CytoSorbents Corp.|CTSO - Company Aggregate Debts|Debts to Book Value CytoSorbents Corporation|CTSO - Company Long-Term Liabilities|Company Short-Term Debts Cytosorbents
Summary company analytics:CTSO cytosorbents.com
Brand item of CytoSorbents Corp

Cytosorbents (CTSO) is scaling the implementation of blood purification systems through global clinical trials and physician training. This ratio of long-term debt to equity reflects the share of loans with a maturity of more than one year relative to capitalization. The metric measures the level of long-term leverage, allowing for the real-time assessment of debt obligation revaluation risks. An increase in the coefficient signals a potential rise in financial pressure on the asset. A stable indicator confirms the resilience of the business expansion strategy.

Key competitors

Long-Term Loans to Capital Ratio DexCom Inc|Penumbra Corp (PEN) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Novanta Photonics (NOVT)|HAE: Long-Term Debt to Capital|inspiresleep.com - Long-Term Liabilities to Capital|Long-Term Debt to Equity PROCEPT BioRobotics Corporation (PRCT)|CNMD - Long-Term Debt to Capital Coefficient|PLSE: Long-Term Debt to Capital|INMD (InMode MD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc PMI|Long-Term Liabilities to Equity surmodics.com|Eversense - Long-Term Debt to Capital|Long-Term Liabilities to Capital NeuroPace Inc NPCE|Long-Term Debt to Equity Ratio TCMD (Tactile Medical)|SNWV - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Outset Medical, Inc. OM|ELMD - Long-Term Loans to Capital Ratio|LENSAR - Long-Term Debt to Capital|AVITA Medical Inc. (RCEL) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PROF|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient APYX (apyxmedical.com)|IceCure Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Long-Term Debt to Capital|SRTS - Long-Term Liabilities to Capital|Long-Term Debt to Capital Zynex, Inc.|electroCore (ECOR) - Long-Term Debt to Capital Ratio|RBOT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Inspira Technologies Oxy B.H.N. Ltd|Long-Term Debt to Capital ICU (SeaStar Medical Holding Corp)|Long-Term Debt to Equity Ratio iridex.com (IRIX)|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Long-Term Debt to Capital|PFSA - Long-Term Debt to Equity|STRATA Skin Sciences (SSKN) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital VERO (Venus Concept Inc.)|Long-Term Liabilities to Capital NUWE|AEMD: Long-Term Debt to Equity|Long-Term Indebtedness to Equity asensus.com ASXC|Long-Term Debt to Equity Ratio AVGR (Avinger, Inc)|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Long-Term Debt to Capital CUTR (Cutera, Inc.)|KNW: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Long-Term Liabilities to Equity|Long-Term Debt to Equity RSLS|Long-Term Debt to Equity Ratio Silk Road Medical Inc